1-1     By:  Lucio, et al.                                    S.B. No. 1456
 1-2           (In the Senate - Filed March 8, 2001; March 13, 2001, read
 1-3     first time and referred to Committee on Health and Human Services;
 1-4     March 28, 2001, reported adversely, with favorable Committee
 1-5     Substitute by the following vote:  Yeas 7, Nays 0; March 28, 2001,
 1-6     sent to printer.)
 1-7     COMMITTEE SUBSTITUTE FOR S.B. No. 1456                   By:  Madla
 1-8                            A BILL TO BE ENTITLED
 1-9                                   AN ACT
1-10     relating to the establishment of a pediatric diabetes research
1-11     advisory committee in the Texas Department of Health.
1-12           BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1-13           SECTION 1.  (a)  The commissioner of public health, in
1-14     consultation with the Texas Diabetes Council, shall establish a
1-15     pediatric diabetes research advisory committee.
1-16           (b)  The pediatric diabetes research advisory committee is
1-17     composed of the chairman of the Texas Diabetes Council or that
1-18     person's designee and not more than 14 additional members appointed
1-19     by the commissioner of public health in consultation with the Texas
1-20     Diabetes Council as follows:
1-21                 (1)  one or more representatives of the Texas
1-22     Department of Health;
1-23                 (2)  one or more representatives of the Juvenile
1-24     Diabetes Research Foundation;
1-25                 (3)  one or more representatives of the American
1-26     Diabetes Association;
1-27                 (4)  one or more research professionals from academic
1-28     or biomedical research institutions in this state currently
1-29     involved in diabetes research; and
1-30                 (5)  one or more representatives of the health care
1-31     industry.
1-32           (c)  The commissioner of public health shall select members
1-33     of the pediatric diabetes research advisory committee based on the
1-34     members' experience, expertise, or special interest in diabetes
1-35     and:
1-36                 (1)  ophthalmology;
1-37                 (2)  pediatric endocrinology;
1-38                 (3)  child health and development;
1-39                 (4)  neuropathy;
1-40                 (5)  genetics;
1-41                 (6)  cardiology; or
1-42                 (7)  immunology.
1-43           (d)  The commissioner of public health, with recommendations
1-44     from the Texas Diabetes Council, shall select a member of the
1-45     pediatric diabetes research advisory committee to serve as the
1-46     presiding officer of the committee.  The presiding officer may not
1-47     be an officer or employee of the state.
1-48           (e)  The pediatric diabetes research advisory committee
1-49     shall:
1-50                 (1)  develop a plan to research pediatric diabetes and
1-51     medical conditions associated with diabetes in this state;
1-52                 (2)  assess the resources and talent of institutions in
1-53     this state as possible sites for research opportunities;
1-54                 (3)  analyze the impact of diabetes on the economy of
1-55     this state and on the health of the residents of this state; and
1-56                 (4)  make recommendations to the legislature and
1-57     governor  concerning research programs in pediatric diabetes and
1-58     funding alternatives for the programs.
1-59           (f)  The pediatric diabetes research advisory committee shall
1-60     meet at least four times as determined by the presiding officer.  A
1-61     professional facilitator with experience in strategic planning
1-62     shall facilitate meetings of the committee.
1-63           (g)  A member of the pediatric diabetes research advisory
1-64     committee may not receive compensation for service on the committee
 2-1     but is entitled to reimbursement for reasonable and necessary
 2-2     travel expenses incurred by the member while conducting the
 2-3     business of the committee as provided by general law and the
 2-4     General Appropriations Act.
 2-5           (h)  Not later than December 1, 2002, the commissioner of
 2-6     public health shall submit a report prepared by the pediatric
 2-7     diabetes research advisory committee to the governor, lieutenant
 2-8     governor, and speaker of the house of representatives regarding
 2-9     pediatric diabetes that comprehensively addresses the issues listed
2-10     in Subsection (e) of this section.
2-11           SECTION 2.  The commissioner of public health shall appoint
2-12     members to the pediatric diabetes research advisory committee not
2-13     later than the 90th day after the effective date of this Act.
2-14           SECTION 3.  The pediatric diabetes research advisory
2-15     committee is abolished January 1, 2003.
2-16           SECTION 4.  This Act expires September 1, 2003.
2-17           SECTION 5.  This Act takes effect immediately if it receives
2-18     a vote of two-thirds of all the members elected to each house, as
2-19     provided by Section 39, Article III, Texas Constitution.  If this
2-20     Act does not receive the vote necessary for immediate effect, this
2-21     Act takes effect September 1, 2001.
2-22                                  * * * * *